Helen,
Quite right.
And I see no mention of where Blood Transfusion Science fits into all
this with BSQR requirements for training and competence etc. etc. etc.


Chris Royle

Service Manager,

Clinical Biochemistry and Haematology Departments,

Royal Brompton and Harefield NHS Trust,

Royal Brompton Hospital,

Sydney Street,

LONDON

SW3 6NP

phone:  + 44 (0)20 7351 8413

fax:      + 44 (0)20 7351 8416

e mail [log in to unmask]


P Save Paper - Do you really need to print this e-mail?


-----Original Message-----
From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Helen Archer (Cwm
Taf NHS Trust)
Sent: 24 October 2008 15:10
To: [log in to unmask]
Subject: Re: Modernising Scientific Careers

I think you sum up nicely my concerns as a BMS as well. It is a step
back for us, entrants will be more generic so will need more in house
training and the length of time taken to complete training seems to be
longer putting an added burden on already over stretched labs.

Helen Archer
Senior Chief BMS
Royal Glamorgan Hospital

-----Original Message-----
From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Griffiths Paul
(RQ3) BCH
Sent: 16 October 2008 16:46
To: [log in to unmask]
Subject: Re: Modernising Scientific Careers

Ian,

We attended the West Midlands meeting this week. Compared to what we
heard earlier in the year, there have been some improvements, i.e. the 3
year rotation would only be within blood sciences (i.e. chemistry,
haematology, immunology and genetics) rather than including cellular
(histo, cyto etc) and infection (micro, virology), which are now
separate rotation schemes. Within that 3 year period, 2 years would be
spent rotating and the final year would be spent in one specialty.

However our main concerns are as follows:

1. There is no provision for specialised subjects e.g. paediatric
metabolic biochemistry. Currently the staff recruited into HST posts in
this subject have already had 4 years basic training in Clinical
Chemistry and hence the necessary grounding to sit the FRCPath whilst
pursuing their narrow specialisation. Under the proposed arrangements,
individuals coming out of the 3 year scheme would only have a maximum of
18 months Clinical Chemistry
experience.

2. There is no facility to recruit individual scientists with highly
specialised skills, from which we benefit, from Universities or Industry
directly into the profession without them going back to trainee status.
There are many examples of such individuals working in departments
across the UK who bring invaluable experience and knowledge to the
service.

3. There is no indication of the percentage of individuals graduating
from the 3 year scheme who would then follow the HSST route versus the
employment route. As this is seen as the fast track route to the higher
scientific and consultant posts, it is clearly relevant to potential
candidates.

4. There is clearly a desire to reduce the number of Higher Education
Institutes providing the courses for these trainees. The concern is that
we may lose some of the excellent MSc courses currently available for
clinical scientists in favour of more generic courses.

Overall there is a concern that, as clinical scientists in Clinical
Chemistry already have an excellent training route, it is unlikely that
all the other HCS groups will be brought up to the same level, but that
we will be 'dumbed-down'.

Regards

Paul Griffiths & Rachel Webster
Clinical Chemistry Department
Birmingham Children's Hospital



-----Original Message-----
From: Clinical biochemistry discussion list
[mailto:[log in to unmask]] On Behalf Of Hembling, Ian
Sent: 16 October 2008 11:19
To: [log in to unmask]
Subject: Modernising Scientific Careers

This is aimed at those of you in the UK especially those who are
Clinical Scientists or Biomedical Scientists.

Most of the listening events are complete now.
I was just interested in anyone's views on Professor Sue Hill's latest
venture and the impact on how we do business.


************************************************************************
***
This e-mail and any files transmitted with it are confidential. If you
are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this e-mail
is prohibited and may be unlawful. If you are not the intended
recipient, please notify the sender immediately by using the reply
function and then permanently delete what you have received.
Content of emails received by this Trust will be subject to disclosure
under the Freedom of Information Act 2000, subject to the specified
exemptions, including the Data Protection Act 1998 and Caldicott
Guardian principles.
This footnote also confirms that, unless otherwise stated, this email
message has been swept by Sophos Anti-virus for the presence of computer
viruses.
************************************************************************
***

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/




DISCLAIMER:


The information contained in this email may be subject to public disclosure under the NHS Code of Openness or the Freedom of Information Act 2000.  Unless the information is legally exempt from disclosure, the confidentiality of this email, and your reply cannot be guaranteed.


The information and material in this email is intended for the use of the intended addressee or the person responsible for delivering it to the intended addressee.  It may contain privileged or confidential information and/or copyright material.


If you receive this email by mistake please advise the sender immediately by using the reply facility in your email software or notify Royal Brompton & Harefield NHS Trust Help Desk on +44(0) 20 7351 8696


Communication is not sent through a secure server; Royal Brompton & Harefield NHS Trust cannot accept responsibility for the accuracy of outgoing electronic mail.  Any views or opinions expressed are solely those of the author and do not represent the view of Royal Brompton & Harefield NHS Trust unless specifically stated.

------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/